Addressing the Global Challenges of COVID-19 and Other Pulmonary Diseases with Microfluidic Technology
Year: 2022
Type: article
Abstract: COVID-19, an infectious pulmonary disease caused by the SARS-CoV-2 virus, has profoundly impacted the world, motivating researchers across a broad spectrum of academic disciplines to gain a deeper understanding and develop effective therapies to this disease. This article presents an engineering perspective on how microfluidic technologies may address some of the challenges presented by COVID-19 and other pulmonary diseases. In particular, this article highlights urgent needs in pulmonary medicine, with an emphasis on technological innovations in the microfluidic manipulation of particles and fluids, and how these innovations may contribute to the study, diagnosis, and therapy of pulmonary diseases.
Source: Engineering
Authors: Yuliang Xie, Ryan Becker, Michael Scott, Kayla Bean, Tony Jun Huang
Institutions: University of Iowa, Duke University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $1,000
Awards: AFS/SERS Saliva-based SARS-CoV-2 Earliest Infection and Antibodies Detection, Collaborative Research: High Resolution Acoustic Manipulation of Single Cells with Integrated MEMS based Phased Arrays, Development of a digital acoustofluidic system for automating liquid handling in biomedical research, Enabling Efficient, Fast, Biocompatible Exosome Separation via Acoustofluidics, Integrated Acoustofluidic Plasmonic Molecular Diagnostic System for Detecting MicroRNA Biomarkers
OpenAlex ID: W4210668908